Development of a quantitative method to evaluate the printability of filaments for fused deposition modeling 3D printing.

Xu, Pengchong; Li, Jiangwei; Meda, Alvin; Osei-Yeboah, Frederick; Peterson, Matthew L; Repka, Michael; Zhan, Xi

Xu, Pengchong; Li, Jiangwei; Meda, Alvin; Osei-Yeboah, Frederick; Peterson, Matthew L; Repka, Michael; Zhan, Xi.

Afiliación

Xu P; Department of Pharmaceutics and Drug Delivery, The University of Mississippi, MS 38677, USA.
Li J; Analytical Development, Biogen, Cambridge, MA, USA.
Meda A; Analytical Development, Biogen, Cambridge, MA, USA.
Osei-Yeboah F; Pharmaceutical Development, Biogen, Cambridge, MA, USA.
Peterson ML; Pharmaceutical Development, Biogen, Cambridge, MA, USA.
Repka M; Department of Pharmaceutics and Drug Delivery, The University of Mississippi, MS 38677, USA.
Zhan X; Pharmaceutical Development, Biogen, Cambridge, MA, USA. Electronic address: xi.zhan@biogen.com.

Int J Pharm ; 588: 119760, 2020 Oct 15.

Article en En | MEDLINE | ID: mdl-32800939

Asunto(s)

Excipientes; Impresión Tridimensional; Industria Farmacéutica; Polímeros; Solubilidad

Palabras clave

3D printing; Filament characterization; Fused deposition modeling; Hot melt extrusion; Printability; Texture analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Excipientes / Impresión Tridimensional Tipo de estudio: Prognostic_studies Idioma: En Revista: Int J Pharm Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google